Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Wolfach

2 clinical trials in Wolfach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Wolfach at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Wolfach

Open in trial search

Parkinson's disease

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Levodopa
  • Sponsor:Universitaetsklinikum Tuebingen AöR

Parkinson's disease

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rotigotine
  • Sponsor:Luye Pharma Switzerland AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Wolfach

What the registry says about research in the country

01 Wolfach
Diseases [C] - Nervous System Diseases [C10]
In Wolfach, the clinical trial activity focuses on nervous system diseases, with Parkinson’s disease as the main condition under study. These trials are currently recruiting and reflect a small but active research setting centered on improving care for people with movement disorders. Focus on Parkinson Disease and related neurodegenerative symptoms Research into treatments aimed at reducing neuropsychiatric complications Evaluation of treatment benefits for symptom control and daily functioning The studies in this area are designed to test how well new or improved therapies can support patients living with Parkinson’s disease and related clinical challenges.
Parkinson Disease
One major line of research in Wolfach examines treatment approaches for Parkinson Disease, especially therapies intended to manage symptoms that are difficult to control with standard care. The goal is to assess whether these options can offer better symptom relief and overall patient benefit. Testing a therapy for dopaminergic-related symptoms Studying effects on behavioral and psychiatric symptoms Comparing new treatment strategies with existing medical care This research helps clarify whether newer approaches can improve quality of life for patients with Parkinson’s disease.
Parkinson's disease
Another trial in this city looks at a Parkinson's disease treatment delivered through a skin patch, with attention to how well it stays in place during use. The study is focused on practical treatment performance and patient convenience. Assessment of skin adhesion for a patch-based therapy Comparison between a test product and a reference product Support for better treatment reliability in everyday use By evaluating how the patch performs on the skin, the research aims to support more dependable delivery of therapy for people with Parkinson’s disease.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.